Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M
Source: SeekingAlpha
2025-02-05 17:05:31 ET
More on Sonoma Pharmaceuticals
- Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
- Historical earnings data for Sonoma Pharmaceuticals
- Financial information for Sonoma Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M
Sonoma Pharmaceuticals Inc.
NASDAQ: SNOA
SNOA Trading
0.85% G/L:
$2.43 Last:
8,534 Volume:
$2.39 Open:
SNOA Latest News
February 10, 2026 04:10:00 pm
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
January 28, 2026 04:15:00 pm
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
November 13, 2025 08:30:00 am
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
SNOA Stock Data
$5,060,701
1,667,054
3.53%
11
N/A
Pharmaceuticals
Healthcare
US
Boulder
